Gravier Pierre
SEC CIK 1984065 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | CFO | 84.0K | $198.7K | $971.5K | 11 | 2023-07-13 | 2026-07-14 |
Most active insiders at PTCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | — | $25.99M |
| 2 | Pauwels Eric | Chief BUSINESS Off | — | $7.48M |
| 3 | SCHMERTZLER MICHAEL | Dir | — | $6.31M |
| 4 | Boulding Mark Elliott | EVP AND CLO | — | $5.96M |
| 5 | Reeve Emma | Dir | — | $4.23M |
| 6 | Klein Matthew B. | CEO, Dir | — | $4.22M |
| 7 | Jacobson Allan Steven | Dir | — | $2.91M |
| 8 | Utter Christine Marie | SVP, CAO | — | $1.94M |
| 9 | Okey Stephanie | Dir | — | $1.46M |
| 10 | Smith Mary L. | Dir | — | $1.43M |
| 13 | Gravier Pierre | CFO | — | $652.9K |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-16 17:20 | 2026-07-14 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | S - Sale | $80.35 | -3,494 | 84.0K | -4% | -$280.7K |
| 2026-02-20 | 2026-02-18 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | S - Sale | $69.36 | -2,992 | 87.3K | -3% | -$207.5K | |
| 2026-01-08 | 2026-01-06 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | S - Sale | $76.95 | -2,139 | 90.3K | -2% | -$164.6K | |
| D | 2026-01-06 | 2026-01-02 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | A - Grant | $0.00 | +20.0K | 92.4K | +28% | $0 |
| 2025-07-17 | 2025-07-15 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | S - Sale | $49.46 | -2,516 | 71.9K | -3% | -$124.4K | |
| M | 2025-02-21 | 2025-02-19+ | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | S - Sale | $50.11 | -2,335 | 74.4K | -3% | -$117.0K |
| D | 2025-01-07 | 2025-01-03 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | A - Grant | $0.00 | +22.5K | 76.8K | +41% | $0 |
| 2024-07-18 | 2024-07-16 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | S - Sale | $34.02 | -2,269 | 53.5K | -4% | -$77.2K | |
| DM | 2024-02-16 | 2024-02-15 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | A - Grant | $0.00 | +22.1K | 55.8K | +66% | $0 |
| 2023-12-14 | 2023-12-12 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | P - Purchase | $25.81 | +7,700 | 33.7K | +30% | +$198.7K | |
| D | 2023-07-17 | 2023-07-13 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | CFO | A - Grant | $0.00 | +26.0K | 26.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations